Publications - IR Sant Pau

Search

01/11/2025 [Translated article] Development of the mobile application Guide to medication reconciliation in the critically ill patient

Cerezuelaa, MM, Morenob, FB, Ramosc, JR, Pintod, AD, Chivae, ED, Rubiof, MV, Gonzálezg, IA, Fernándezh, CB, Morali, LD, Lugeaj, AE, Garciak, MAA, Garcial, TB, Sacristánm, SC, Fernándezh, MA, Pérezn, SO, Tomáso, LPD. [Translated article] Development of the mobile application Guide to medication reconciliation in the critically ill patient. Farmacia Hospitalaria. 2025; 49(6)DOI:10.1016/j.farma.2025.06.007. PMID:40681428. IF:(Q/D).

11/10/2025 Retrospective Cohort Study of Intrapericardial Cisplatin for Risk Reduction of Malignant Pericardial Effusion Recurrence

Muñoz-Carrillo, FJ, Reyes, RM, Pesántez, D, Carrera, G, Cascos, E, Castro, P, Fernández-Méndez, S, Font, C, González-Aguado, L, Grafiá, I, Llavata, L, Monge-Escartín, I, Padrosa, J, Reguart, N, Téllez, A, Tuca, A, Viladot, M, Zamora-Martínez, C, Amorós-Reboredo, P, Marco-Hernández, J. Retrospective Cohort Study of Intrapericardial Cisplatin for Risk Reduction of Malignant Pericardial Effusion Recurrence. Current Oncology. 2025; 32(10)DOI:10.3390/curroncol32100568. PMID:41149488. IF:3.400(Q2/4D).

01/10/2025 Standard Versus Reduced-Doses of Post-Transplant Cyclophosphamide in HLA Matched (10/10) Peripheral Blood Stem Cell Transplantation

Redondo, S, García-Cadenas, I, Esquirol, A, Iranzo, E, Arguello-Tomas, M, Saavedra, S, Oñate, G, Caballero, AC, Garrido, A, López, J, Muntañola, A, Paviglianiti, A, Portos, JM, Moreno-Martinez, ME, Riba, M, Sierra, J, Briones, J, Martino, R. Standard Versus Reduced-Doses of Post-Transplant Cyclophosphamide in HLA Matched (10/10) Peripheral Blood Stem Cell Transplantation. EUROPEAN JOURNAL OF HAEMATOLOGY. 2025; 115(4)DOI:10.1111/ejh.70010. PMID:40697075. IF:2.300(Q2/5D).

01/10/2025 Sex and gender differences in cancer pathogenesis and pharmacology

Bernardez, B, Higuera, O, Martinez-Callejo, V, Cardeña-Gutiérrez, A, Rodríguez, JAM, Bertrán, AS, Majem, M, Moreno-Martínez, ME. Sex and gender differences in cancer pathogenesis and pharmacology. Clinical & Translational Oncology. 2025; 27(10)DOI:10.1007/s12094-025-03894-1. PMID:40164824. IF:2.500(Q3/6D).

01/10/2025 Comparison of antimicrobial consumption indicators in the emergency department

Ruiz-Ramos, J, Monje-López, AE, Escolà-Vergé, L, Herrera-Mateo, S, Hernández-Ontiveros, H, Duch-Llorach, P, Fernández-de-Gamara-Martinez, E, Rivera-Martinez, MA, Pereira-Batista, CS, López-Contreras, J. Comparison of antimicrobial consumption indicators in the emergency department. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2025; 43(8)DOI:10.1016/j.eimc.2025.01.009. PMID:. IF:2.500(Q2/5D).

29/09/2025 Emergency Department Reconsultations After a Secondary Prevention Bundle for Medication-Related Problems: A Retrospective Cohort Study

Plaza-Díaz, A, Juanes-Borrego, A, Sanz-Lopez, N, González-Bueno, J, Fernández-Morató, J, García-Peláez, M, Ruiz-Ramos, J. Emergency Department Reconsultations After a Secondary Prevention Bundle for Medication-Related Problems: A Retrospective Cohort Study. Journal of Clinical Medicine. 2025; 14(19)DOI:10.3390/jcm14196907. PMID:41095987. IF:2.900(Q1/2D).

01/09/2025 Map of the residency rotations for hospital pharmacy internal resident in Spain

Aguilar, CC, Negro-Vega, E, de Gamarra-Martinez, EF, Castro, BM, Abánades, MP, Capafons, SR, Conde, CPM. Map of the residency rotations for hospital pharmacy internal resident in Spain. Farmacia Hospitalaria. 2025; 49(5)DOI:10.1016/j.farma.2025.03.014. PMID:40348652. IF:(Q/D).

01/09/2025 Biosimilars and reference biological medicines in the treatment of rheumatoid arthritis: a multicenter cross-sectional study in Catalonia, Spain

Marin, JM, Molina-Olano, M, Sola, NR, Miserachs-Aranda, N, Alcón, PM, De Pourcq, JT, Ribas, CQ, Trias, LB, Fernández-Cañabate, E, González-Valdivieso, J, Figueiredo-Escribá, C, Delgado-Hernández, R, Braza, AJ, Lastra, CF, Mariño, EL, Modamio, P. Biosimilars and reference biological medicines in the treatment of rheumatoid arthritis: a multicenter cross-sectional study in Catalonia, Spain. CLINICAL RHEUMATOLOGY. 2025; 44(9)DOI:10.1007/s10067-025-07568-9. PMID:40707848. IF:2.800(Q2/5D).

01/09/2025 Sex-related differences in the efficacy and toxicity of cancer treatments

Bertrán, AS, Rodríguez, JAM, Cardeña-Gutiérrez, A, Martinez-Callejo, V, Higuera, O, Bernardez, B, Moreno-Martínez, ME, Majem, M. Sex-related differences in the efficacy and toxicity of cancer treatments. Clinical & Translational Oncology. 2025; 27(9)DOI:10.1007/s12094-025-03893-2. PMID:40153220. IF:2.500(Q3/6D).

26/08/2025 Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma

Anguera, G, Gallego, O, Llobet, M, Berga, N, Moreno-Martinez, ME, Leon, X, Kratz, C, Garcia-Escudero, R, Minguillón, J, Surrallés, J. Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma. BMC CANCER. 2025; 25(1)DOI:10.1186/s12885-025-14619-6. PMID:40859225. IF:3.400(Q2/4D).

18/08/2025 Integrating Global Surveillance, Local Action, and Innovative Stewardship Against Antimicrobial Resistance

Ruiz-Ramos, J. Integrating Global Surveillance, Local Action, and Innovative Stewardship Against Antimicrobial Resistance. Antibiotics-Basel. 2025; 14(8)DOI:10.3390/antibiotics14080835. PMID:40868029. IF:4.600(Q1/2D).

08/08/2025 The Role of Pharmacogenetic Biomarkers in Pain

da Silva, IM, Plaza-Díaz, A, Ruiz-Ramos, J, Juanes-Borrego, A, Riera, P. The Role of Pharmacogenetic Biomarkers in Pain. Biomedicines. 2025; 13(8)DOI:10.3390/biomedicines13081935. PMID:40868188. IF:3.900(Q1/3D).

01/07/2025 Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to ß-blockers: A double-blind, placebo-controlled, randomized trial

Alvarado-Tapias, E, Brujats, A, Puente, A, Ardevol, A, Rodriguez-Arias, A, Fajardo, J, Pavel, O, Garcia-Guix, M, Aracil, C, Poca, M, Cuyàs, B, Cantó, E, Montañés, R, Garcia-Osuna, A, Escorsell, A, Torras, X, Villanueva, C. Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to ß-blockers: A double-blind, placebo-controlled, randomized trial. HEPATOLOGY. 2025; 82(1)DOI:10.1097/HEP.0000000000001148. PMID:39509369. IF:15.800(Q1/1D).

01/07/2025 Successful implementation of a bundle to prevent increased excessive-spectrum antimicrobial use under new EUCAST susceptibility definitions: a quasi-experimental study in a tertiary hospital

Duch-Llorach, P, Simonetti, AF, Figueras-Roig, A, Rivera, A, de Gamarra-Martínez, EF, Gras-Martin, L, Moreno-Martinez, ME, Ramos, JR, Zarate-Tamames, B, Navarro, F, López-Contreras, J, Escolà-Vergé, L. Successful implementation of a bundle to prevent increased excessive-spectrum antimicrobial use under new EUCAST susceptibility definitions: a quasi-experimental study in a tertiary hospital. JOURNAL OF HOSPITAL INFECTION. 2025; 161DOI:10.1016/j.jhin.2025.04.016. PMID:40306370. IF:3.100(Q1/3D).

01/05/2025 Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy

Colominas-Gonzalez, E, De Antonio, M, Masip, M, Conde, MTM, Cardona, G, Restituto, DF, Comas, D, Roch, MA, Lopez, B, Torres-Bondia, FI, Retamero, A, Knobel, H, Luque, S. Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy. EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2025; 32(3)DOI:10.1136/ejhpharm-2024-004118. PMID:38802166. IF:1.500(Q4/8D).

17/04/2025 HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+lymphoma

Caballero, AC, Ujaldón-Miró, C, Pujol-Fernández, P, Montserrat-Torres, R, Guardiola-Perello, M, Escudero-López, E, Garcia-Cadenas, I, Esquirol, A, Martino, R, Jara-Bustamante, P, Ezquerra, P, Soria, JM, Iranzo, E, Moreno-Martinez, ME, Riba, M, Sierra, J, Alvarez-Fernández, C, Escribà-Garcia, L, Briones, J. HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+lymphoma. BLOOD. 2025; 145(16)DOI:10.1182/blood.2024026758. PMID:39841453. IF:23.100(Q1/1D).

01/04/2025 [Translated article] Evaluation of the safety of medication-use systems in hospital emergency services

Otero, MJ, Díez, MA, Cartelle, HE, Hernández, SJ, Blanco, IM, Ucha, MS, Perrín, RS, Ramos, JR. [Translated article] Evaluation of the safety of medication-use systems in hospital emergency services. Farmacia Hospitalaria. 2025; 49(2)DOI:10.1016/j.farma.2024.10.015. PMID:39580345. IF:(Q/D).

01/04/2025 Evaluation of the safety of medication-use systems in hospital emergency services

Otero, MJ, Díez, MA, Cartelle, HE, Hernández, SJ, Blanco, IM, Ucha, MS, Perrín, RS, Ramos, JR. Evaluation of the safety of medication-use systems in hospital emergency services. Farmacia Hospitalaria. 2025; 49(2)DOI:10.1016/j.farma.2024.07.007. PMID:39181756. IF:(Q/D).

01/03/2025 Designing an integrated care pathway for spondyloarthritis: A Lean Thinking approach

Lobo-Prat, D, Sainz, L, Laiz, A, De Dios, A, Fontcuberta, L, Fernández, S, Masip, M, Riera, P, Pages-Puigdemont, N, Ros, S, Gomis-Pastor, M, Corominas, H. Designing an integrated care pathway for spondyloarthritis: A Lean Thinking approach. JOURNAL OF EVALUATION IN CLINICAL PRACTICE. 2025; 31(2)DOI:10.1111/jep.14132. PMID:39253893. IF:2.100(Q2/3D).

01/03/2025 Development and Clinical Validation of Liquid Chromatography-Tandem Mass Spectrometry for Measuring Ruxolitinib in Steroid-Refractory Graft-Versus-Host Disease: A First Step Towards Optimized Treatment

Redondo, S, Costa, M, Moreno-Martinez, ME, Arguello-Tomas, M, Riba, M, Aso, O, Iranzo, E, Esquirol, A, Sierra, J, Briones, J, Martino, R, Zapico, E, Garcia-Cadenas, I. Development and Clinical Validation of Liquid Chromatography-Tandem Mass Spectrometry for Measuring Ruxolitinib in Steroid-Refractory Graft-Versus-Host Disease: A First Step Towards Optimized Treatment. EUROPEAN JOURNAL OF HAEMATOLOGY. 2025; 114(3)DOI:10.1111/ejh.14349. PMID:39545520. IF:2.300(Q2/5D).

01/01/2025 Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine

de Dios, A, Pages-Puigdemont, N, Ojeda, S, Riera, P, Pelegrín, R, Morollon, N, Belvís, R, Real, J, Masip, M. Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine. HEADACHE. 2025; 65(1)DOI:10.1111/head.14827. PMID:39268992. IF:4.000(Q1/2D).

01/11/2024 Association of Benzodiazepine Prescription With Short-Term Prognosis in Elderly Patients Attended in Emergency Department: Results From the EDEN PROJECT

Ruiz-Ramos, J, Alquézar-Arbé, A, Juanes-Borrego, A, González-del-Castillo, J, Jacob, J, Burillo, G, Aguiló, S, Fernandez, C, Plaza-Díaz, A, Millán-Soria, J, Jara-Torres, G, López-Delmas, N, Muñoz-Triano, E, Martín-Durán, C, Delgado-Sardina, V, Gallardo-Sánchez, BA, Osorio-Quispe, IG, Real-López, A, Gordo-Remartinez, S, González-Ferreira, L, alvarez-Madrigal, A, Martínez-Ibarreta-Zorita, J, Sanchez-Moreno, M, Sanchez-Moreno, M, Sánchez-Serrano, JA, Hernando-Fernández, R, Turcios-Torres, J, Ponte-Márquez, P, Miró, O. Association of Benzodiazepine Prescription With Short-Term Prognosis in Elderly Patients Attended in Emergency Department: Results From the EDEN PROJECT. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024; 33(11)DOI:10.1002/pds.70044. PMID:39477694. IF:2.400(Q2/4D).

25/10/2024 Adverse reactions to Janus kinase inhibitors: Study of their incidence and predictive factors in patients with rheumatoid arthritis

Martinez-Molina, C, Tey, JMG, Ruiz-Ramos, J, Feliu, A, Puig-Campmany, M, Vidal, S, Corominas, H. Adverse reactions to Janus kinase inhibitors: Study of their incidence and predictive factors in patients with rheumatoid arthritis. MEDICINA CLINICA. 2024; 163(8)DOI:10.1016/j.medcli.2024.05.007. PMID:39003114. IF:2.100(Q2/3D).

23/10/2024 Transforming respiratory diseases management: a CMO-based hospital pharmaceutical care model

Zarate-Tamames, B, Garin, N, Calvin-Lamas, M, Jornet, S, Martinez-Simon, JJ, Garcia-Gil, S, Garcia-Rebolledo, EM, Morillo-Verdugo, R. Transforming respiratory diseases management: a CMO-based hospital pharmaceutical care model. Frontiers in Pharmacology. 2024; 15DOI:10.3389/fphar.2024.1461473. PMID:39512818. IF:4.800(Q1/2D).

01/10/2024 DEVELOPMENT AND CLINICAL VALIDATION OF LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY FOR INDIVIDUALIZED RUXOLITINIB ADJUSTMENT IN FUTURE CASES OF STEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE

Redondo, S, Costa, M, Moreno-Martinez, ME, Riba, M, Aso, O, Iranzo, E, Esquirol, A, Sierra, J, Briones, J, Martino, R, Zapico, E, Garcia-Cadenas, I. DEVELOPMENT AND CLINICAL VALIDATION OF LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY FOR INDIVIDUALIZED RUXOLITINIB ADJUSTMENT IN FUTURE CASES OF STEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

01/10/2024 EFFICACY AND SAFETY OF REDUCED-DOSES OF POST-TRANSPLANT CYCLOPHOSPHAMIDE IN PERIPHERAL BLOOD STEM CELL TRANSPLANTATION OUTSIDE THE HAPLOIDENTICAL SETTING

Redondo, S, Arrufat, A, Esquirol, A, Saavedra, S, Arguello-Tomas, M, Caballero, AC, O ate, G, Garrido, A, Lopez, J, Miqueleiz, S, Portos, JM, Iranzo, E, Moreno-Martinez, ME, Riba, M, Sierra, J, Briones, J, Garc a-Cadenas, I, Martino, R. EFFICACY AND SAFETY OF REDUCED-DOSES OF POST-TRANSPLANT CYCLOPHOSPHAMIDE IN PERIPHERAL BLOOD STEM CELL TRANSPLANTATION OUTSIDE THE HAPLOIDENTICAL SETTING. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

01/10/2024 EVALUATION OF MENTAL HEALTH THROUGH AN EHEALTH PLATFORM IN THE MANAGEMENT OF ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS (MYMEDULA STUDY): DESCRIPTIVE ANALYSIS

Tobajas, E, Carretero, G, De Dios, A, Redondo, S, Vallv , M, Esquirol, A, Aso, O, Triquell, M, Moreno-Martinez, ME, Riba, M, Blasco, A, Martino, R, Gomis-Pastor, M, Garc a-Cadenas, I. EVALUATION OF MENTAL HEALTH THROUGH AN EHEALTH PLATFORM IN THE MANAGEMENT OF ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS (MYMEDULA STUDY): DESCRIPTIVE ANALYSIS. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

01/10/2024 MOBILE HEALTH IN THE MANAGEMENT OF ALLOGENIC STEM CELL TRANSPLANT RECIPIENTS (MY-MEDULA STUDY): PRELIMINARY RESULTS OF THE CLINICAL TRIAL

Redondo, S, De Dios, A, Vallve, M, Real, J, Triquell, M, Aso, O, Esquirol, A, Moreno-Martinez, M, Riba, M, Ruiz, J, Tobajas, E, Sierra, J, Briones, J, Martino, R, Gomis-Pastor, M, Garcia-Cadenas, I. MOBILE HEALTH IN THE MANAGEMENT OF ALLOGENIC STEM CELL TRANSPLANT RECIPIENTS (MY-MEDULA STUDY): PRELIMINARY RESULTS OF THE CLINICAL TRIAL. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

01/10/2024 NURSING ROLE IN IMPLEMENTING EHEALTH FOR ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS: INITIAL FINDINGS FROM THE MY-MEDULA STUDY'S RANDOMIZED CLINICAL TRIAL

Triquell, M, Redondo, S, De Dios, A, Vallv , M, Real, J, Esquirol, A, Martinez, EM, Riba, M, Tobajas, E, Sierra, J, Briones, J, Martino, R, Ruiz, J, Pastor, MG, Cadenas, IG, Aso, O. NURSING ROLE IN IMPLEMENTING EHEALTH FOR ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS: INITIAL FINDINGS FROM THE MY-MEDULA STUDY'S RANDOMIZED CLINICAL TRIAL. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

13/09/2024 A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT)

Domingos, V, Nezvalova-Henriksen, K, Dadkhah, A, Moreno-Martinez, ME, Ben Hassine, K, Pires, V, Kroeger, N, Bauters, T, Hassan, M, Duncan, N, Kalwak, K, Ansari, M, Langebrake, C, Admiraal, R. A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT). BONE MARROW TRANSPLANTATION. 2024; 59(12)DOI:10.1038/s41409-024-02413-0. PMID:39271948. IF:5.200(Q1/1D).

01/09/2024 Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review

Gras-Martín, L, Plaza-Diaz, A, Zarate-Tamames, B, Vera-Artazcoz, P, Torres, OH, Bastida, C, Soy, D, Ruiz-Ramos, J. Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review. Antibiotics-Basel. 2024; 13(9)DOI:10.3390/antibiotics13090801. PMID:39334976. IF:4.600(Q1/2D).

01/09/2024 Guide for the efficient and safe delivery of Telepharmacy

Collado-Borell, R, Gomis-Pastor, M, Rodríguez-Cabezas, M, Parro-Martín, A, Linares-Alarcón, A, Gutiérrez, E, González-Corominas, E, Fernández-Polo, A, Domínguez-Cantero, M, Arrondo-Velasco, A, Morillo-Verdugo, R. Guide for the efficient and safe delivery of Telepharmacy. Health Policy and Technology. 2024; 13(4)DOI:10.1016/j.hlpt.2024.100899. PMID:. IF:3.700(Q1/1D).

01/08/2024 Hospital pharmacy towards 2030

de Gamarra-Martínez, EF, Tortajada-Goitia, B, Corte-García, JJ, Martín-Herranz, I, García-Gil, M, de la Fuente, JS, Nicolás-Picó, J. Hospital pharmacy towards 2030. Farmacia Hospitalaria. 2024; 48DOI:10.1016/j.farma.2024.05.004. PMID:39097369. IF:(Q/D).

01/07/2024 Physicochemical Compatibility of Ceftolozane-Tazobactam with Parenteral Nutrition

De Pourcq, JT, Riera, A, Gras, L, Garin, N, Busquets, MA, Cardenete, J, Cardona, D, Riera, P. Physicochemical Compatibility of Ceftolozane-Tazobactam with Parenteral Nutrition. Pharmaceuticals. 2024; 17(7)DOI:10.3390/ph17070896. PMID:39065746. IF:4.800(Q1/2D).

01/07/2024 Burden of Disease Study of Patients with Neovascular Age-Related Macular Degeneration in Spain

Abraldes, MJ, Calvo, P, Lechuga, MG, Merino, M, Lorenzo, TM, Maravilla-Herrera, P, Jiménez, BG, Ruiz-Moreno, JM. Burden of Disease Study of Patients with Neovascular Age-Related Macular Degeneration in Spain. Ophthalmology and Therapy. 2024; 13(7)DOI:10.1007/s40123-024-00960-9. PMID:38771461. IF:3.200(Q1/2D).

01/07/2024 Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain

Ruiz-Moreno, JM, Lechuga, MG, Calvo, P, Merino, M, Lorenzo, TM, Maravilla-Herrera, P, Jiménez, BG, Abraldes, MJ. Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain. Ophthalmology and Therapy. 2024; 13(7)DOI:10.1007/s40123-024-00959-2. PMID:38771462. IF:3.200(Q1/2D).

01/07/2024 Pharmaceutical care in respiratory diseases: Current situation and opportunities for Hospital Pharmacy in Spain

Garin, N, Zarate-Tamames, B, Jornet, S, García, EM, López-Gil, MD, Romero, G, Del Estal, J. Pharmaceutical care in respiratory diseases: Current situation and opportunities for Hospital Pharmacy in Spain. Farmacia Hospitalaria. 2024; 48(4)DOI:10.1016/j.farma.2024.02.006. PMID:38580504. IF:(Q/D).

11/06/2024 Optimization of a home hospitalization program for hematopoietic stem cell transplantation with ehealth integration and clinical pharmacist involvement

Moreno-Martinez, ME, Riba, M, García-Cadenas, I, Esquirol, A, Yusta, M, Redondo, S, De Dios, A, Portos, JM, Aso, O, Marcos-Fendian, A, Font, N, Briones, J, Martino, R, Feliu, A. Optimization of a home hospitalization program for hematopoietic stem cell transplantation with ehealth integration and clinical pharmacist involvement. Frontiers in Immunology. 2024; 15DOI:10.3389/fimmu.2024.1397115. PMID:38919607. IF:5.900(Q1/2D).

01/06/2024 Clinical Validation of Digital Healthcare Solutions: State of the Art, Challenges and Opportunities

Gomis-Pastor, M, Berdún, J, Borrás-Santos, A, López, AD, Rama, BFM, García-Esquirol, O, Gratacòs, M, Rodríguez, GDO, Cruz, RP, Real, J, Ferrer, JBI, Comella, A. Clinical Validation of Digital Healthcare Solutions: State of the Art, Challenges and Opportunities. Healthcare. 2024; 12(11)DOI:10.3390/healthcare12111057. PMID:38891132. IF:2.700(Q2/4D).

01/06/2024 First-line pembrolizumab for lung cancer in a Spanish real-world study.

Burgos, A, Calleja, T, Ibáñez, C, Valencia, CM, Orallo, C, Titos, JC, Conde, D, Diaz, S, Matilla, B, Lizeaga, G, Sánchez, C, Pozo, JFM, Jimenez, S, Jiménez, I, Díez, R, Garrido, M, Larrosa, M, Martinez, MJ, Moreno, E, Campelo, RG. First-line pembrolizumab for lung cancer in a Spanish real-world study.. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).